Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AZN - Pieris Pharmaceuticals: Expanding Elarekibep (AZD1402) Trial Finally Has Active And Completed Sites

AZN - Pieris Pharmaceuticals: Expanding Elarekibep (AZD1402) Trial Finally Has Active And Completed Sites

AstraZeneca PLC

2023-05-17 00:55:30 ET

Summary

  • Expanding Elarekibep (AZD1402) trial finally has active/completed sites.
  • Major investment risk exists because of the Company's cash burn rate.
  • Potential deals on PRS-220 and PRS-343 could bolster the Company's balance sheet.
  • The Company's low market capitalization compared with the value proposition of current partnerships, offers high potential upside to the current share price.

For further details see:

Pieris Pharmaceuticals: Expanding Elarekibep (AZD1402) Trial Finally Has Active And Completed Sites
Stock Information
Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com
Menu
AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...